While that happens, the peptide also counteracts the harmful effects of both NO blockade and NO overstimulation
But reducing body weight is only one piece of a much larger metabolic puzzle
Developed by Eli Lilly, this triple agonist peptide activates three key hormone receptors GLP-1 , GIP , and glucagon receptors influencing glucose metabolism, energy expenditure, and fat oxidation
A 2024 phase 3 RCT from China (n=458) demonstrated significantly greater reduction in modified Toronto Clinical Neuropathy Score (mTCNS) with ALC 1,500 mg/day compared to placebo (-6.9 vs -4.7 points
The staff is very friendly
Our experienced coaches work with you to create sustainable lifestyle changes, develop healthy habits, and overcome obstacles